期刊文献+

肺干细胞标记物的研究与进展 被引量:2

Research and development of pulmonary stem cell markers
下载PDF
导出
摘要 通过应用cells in induced group cultured for 2 weeks(von kossa staining)标记的胸腺嘧啶(3H-TdR)或5-溴脱氧尿核苷(BrdU)的渗入进行标记,发现肺组织的基底细胞、Clara细胞和肺泡II型上皮细胞可能具有干细胞特征,能最终分化形成气道上皮。目前对于肺干细胞的研究进展缓慢,究其原因主要是肺组织和气道具有复杂的内在结构,呼吸系统至少包含40种不同类型的细胞,呼吸上皮本身只有极低的生长更新率和非常有限的再生能力,同时肺干细胞的表面标志物也缺乏特异性,只能借助其他组织已知的干细胞标记物进行对比观察。对肺干细胞标记物的研究集中在Sca-1、ABCG2/Bcrp1、滞留细胞标记分子、细胞表面分子、细胞角蛋白、CCSP等方面。对肺癌发生的深入研究发现肺癌可能源于正常肺干细胞的突变,此对于肺癌的发生及治疗提供了更多的思路和方向。 By incorporation of tritiated thymidine or 5-bromodeoxyuridine and using them as the markers, we found that the basal cells, Clara cells and type Ⅱ alveolar epithelial cells in the pulmonary tissues may in some way behave like stem cells and can eventually differentiate into respiratory tract epithelium. The slow progress of researches on pulmonary stern cells up to date has its root in the complex structure of pulmonary tissues and respiratory tracts, which is demonstrated by the facts that the respiratory system is composed of at least 40 types of cells, plus that the growth, renewal, and regeneration rate or capacity of respiratory epithelium are extremely limited. Mean while, there have been no specific stem cell markers for pulmonary and lung cancer, so researchers rely on stem cell markers borrowed from other systems to search for stem cells in pulmonary system. At present, the studies of lung stem cell markers were focused on Sca-1, ABCG2/Bcrp 1, cell retaining marker, surface marker, cell keratin and CCSP Recently the lung stem cells have been shown to be the targets of transformation during lung carcinogenesis, which has provide more thoughts and direction for the occurrence and treatment of lung cancer.
出处 《中国组织工程研究与临床康复》 CAS CSCD 北大核心 2008年第47期9347-9350,共4页 Journal of Clinical Rehabilitative Tissue Engineering Research
  • 相关文献

参考文献29

  • 1Ailles LE, Weissman IL. Cancer stem cells in solid tumors. Curr Opin Biotechnol 2007;18(5):460-466.
  • 2Neuringer IP, Randell SH.Lung stem cell .update: promise and controversy. Monaldi Arch Chest Dis 2006;65(1):47-51.
  • 3Kotton DN, Fine A. Lung stem cells. Cell Tissue Res 2008;331(1):145-156.
  • 4Holmes C, Stanford WL. Concise Review: Stem Cell Antigen-l: Expression, Function, and Enigma. Stem Cells 2007;25 ( 6 ): 1339 - 1347.
  • 5Kotton DN, Summer RS, Sun-X,et al.Stem cell antigen-1 expression in the pulmonary vascular endothelium Am J Physiol Lung Cell Mol Physiol 2003;284 (6) :990-996.
  • 6Kim CE Jackson EL, Woolfenden AE, et al. Identification of bronchioalveolar stem cells in normal lung and lung cancer . Cell 2005;121(6) :823-835.
  • 7Zhou S, Schuetz JD, Bunting KD, et al. The ABC transporter Bcrpl/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 2001;7 (9) :1028-1034.
  • 8Goodell MA, Rosenzweig M, Kim H, et al. Dye efflux studies suggest that hematopoietic stem cells expressing low or undetectable levels of CD34 antigen exist in multiple species. Nat Med 1997;3 (12) :1337-1345.
  • 9Asakura A, Rudnicki MA. Side population cells from diverse adult tissues are capable of in vitro hematopoietic differentiation. Exp Hematol 2002; 30 1339-1345.
  • 10Summer R, Kotton DN. Side population cells and Bcrpl expression in lung. Am J Physiol Lung Cell Mol Physiol 2003; 285:97-104.

同被引文献13

引证文献2

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部